IDIX
Teva Pharmaceutical resume a deal-making strategy that made it one of the most acquisitive drug companies of the past decade. Could one of these biotech takeover candidates be the next target?
Published:
The analysts at UBS are not only bullish on the biotechnology sector, they think there is a very distinct possibility that some of the top names may also become takeover targets this year.
Published:
Source: ThinkstockIdenix Pharmaceuticals Inc. (NASDAQ: IDIX) was the biggest gainer of all listed stocks on Friday with a rally of 40%. Its trading volume of almost 9.2 million shares was almost...
Published:
Stocks are showing the concern over the shenanigans taking place in Washington, and investors have to worry which stocks they should be buying, selling or avoiding. It turns out that analysts think...
Published:
Last Updated:
U.S. equity markets opened higher this morning after yesterday’s bloodbath. There was no economic data of note released today in either Asia or the U.S. In Europe, the eurozone’s current account...
Published:
Last Updated:
Source: Jon OggInvestors and traders are often on the hunt for fresh research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall...
Published:
Last Updated:
Source: thinkstockHere are today’s five biggest gaining stocks at closing:Stereotaxis Inc. (NASDAQ: STXS) is up 30.2% at $2.33.Novogen Ltd. (NASDAQ: NVGN) is up 18.8% at $5.24.SemiLEDS Corp....
Published:
Last Updated:
Source: ThinkstockIdenix Pharmaceuticals Inc. (NASDAQ: IDIX) was covered this morning in our analyst upgrades and downgrades daily summary, but call is worth a closer look. Deutsche Bank initiated...
Published:
Last Updated:
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Wednesday.Check Point Software Technologies Ltd. (NASDAQ: CHKP) started as...
Published:
Last Updated:
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Wednesday.Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) raised to Buy...
Published:
Last Updated:
Source: Photo by Spencer Platt/Getty ImagesStocks are mixed Monday, with the Dow Jones Industrial Average down 0.23%, the Nasdaq up 0.15% and the S&P 500 down 0.05%. Today’s market winners include...
Published:
Last Updated:
Source: Jon OggThese are some of today’s top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Tuesday.Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) Started as...
Published:
Last Updated:
News from Abbott Laboratories (NYSE: ABT) on its positive Phase II study results from two different interferon-free hepatitis C treatment has the entire drug sector up in arms as it pertains to...
Published:
Last Updated:
US equities opened strongly this morning and managed to maintain solid gains throughout the day. The in-line earnings report last night from Alcoa Inc. (NYSE: AA) and higher commodity prices —...
Published:
Last Updated: